Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer
Clinical trial NCT00093626 · COMPLETED
Trial details
- NCT number
- NCT00093626
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2007-09-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.